|
$532,311
|
To provide nonpartisan information and technical assistance to stakeholders to help lower prescription drug prices and commercial sector prices.
|
2021 - 2022
|
LJAF
|
|
$916,380
|
To provide information and technical support to help policymakers lower health care costs.
|
2019 - 2021
|
LJAF
|
|
$112,120
|
To develop a white paper outlining issues that are key for the succesful distribution of a COVID-19 vaccine.
|
2020 - 2022
|
LJAF
|
|
$74,497
|
To create an evidence-base to support the policy debate related to high prescription drug pricing.
|
2019 - 2020
|
LJAF
|
|
$207,774
|
To (i) research and analyze anticompetitive behaviors impacting prescription drug pricing, and (ii) provide nonpartisan information and technical support to key stakeholders and policymakers.
|
2019 - 2020
|
LJAF
|
|
$248,354
|
To inform ongoing investigations into pharmaceutical industry pricing practices.
|
2020 - 2021
|
LJAF
|
|
$503,352
|
To provide nonpartisan information and technical support to key stakeholders regarding prescription drug policy and publicly disseminate educational resources.
|
2018 - 2019
|
LJAF
|
